About Wilms tumor protein
Wilms tumor protein (WT1) is a protein
from Homo sapiens identified by UniProt accession
P19544, 449 residues long.
MolForge cross-references it against 0 known binders and
984 disease associations.
Target properties
| Protein name | Wilms tumor protein |
| UniProt accession | P19544 |
| Gene | WT1 |
| Organism | Homo sapiens |
| Length | 449 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (984)
Diseases linked to this target (Open Targets).
- Wilms tumor 1 · score 0.80
- Denys-Drash syndrome · score 0.80
- Frasier syndrome · score 0.77
- nephrotic syndrome, type 4 · score 0.74
- Meacham syndrome · score 0.73
- Malignant Mesothelioma · score 0.66
- hereditary Wilms tumor · score 0.62
- WAGR syndrome · score 0.57
- familial idiopathic steroid-resistant nephrotic syndrome · score 0.56
- acute myeloid leukemia · score 0.55
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-P19544-F1 | alphafold | PREDICTED | 50.80 | — |
Amino-acid sequence (449 residues)
MGSDVRDLNA LLPAVPSLGG GGGCALPVSG AAQWAPVLDF APPGASAYGS LGGPAPPPAP PPPPPPPPHS FIKQEPSWGG AEPHEEQCLS AFTVHFSGQF TGTAGACRYG PFGPPPPSQA SSGQARMFPN APYLPSCLES QPAIRNQGYS TVTFDGTPSY GHTPSHHAAQ FPNHSFKHED PMGQQGSLGE QQYSVPPPVY GCHTPTDSCT GSQALLLRTP YSSDNLYQMT SQLECMTWNQ MNLGATLKGV AAGSSSSVKW TEGQSNHSTG YESDNHTTPI LCGAQYRIHT HGVFRGIQDV RRVPGVAPTL VRSASETSEK RPFMCAYPGC NKRYFKLSHL QMHSRKHTGE KPYQCDFKDC ERRFSRSDQL KRHQRRHTGV KPFQCKTCQR KFSRSDHLKT HTRTHTGKTS EKPFSCRWPS CQKKFARSDE LVRHHNMHQR NMTKLQLAL
Explore Wilms tumor protein with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets